Stakeholder Engagement In a Comparative Effectiveness/Implementation Study to Prevent Staphylococcus Aureus Infection Recurrence: CA-MRSA Project (CAMP2)

Prog Community Health Partnersh. 2022;16(1):45-60. doi: 10.1353/cpr.2022.0005.


Background: Methicillin-resistant or methicillin-sensitive Staphylococcus aureus skin and soft tissue infections pose serious clinical and public health challenges. Few protocols exist for outpatient education, decolonization and decontamination.

Objectives: This trial implemented infection prevention protocols in homes via community health workers/Promotoras.

Methods: We engaged clinicians, patient stakeholders, clinical and laboratory researchers, New York-based federally qualified health centers and community hospital emergency departments. The Clinician and Patient Stakeholder Advisory Committee (CPSAC) convened in person and remotely for shared decision-making and trial oversight.

Results: The intervention trial consented participants with skin and soft tissue infections from Methicillin-resistant Staphylococcus aureus or methicillin-sensitive Staphylococcus aureus, completed home visits, obtained surveillance cultures from index patients and household members and sampled household environmental surfaces at baseline and three months.

Lessons learned: The retention of the CPSAC during the trial demonstrated high levels of engagement.

Conclusions: CPSAC was highly effective throughout design and execution by troubleshooting recruitment and home visit challenges.

Trial registration: NCT02566928.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Community-Acquired Infections* / drug therapy
  • Community-Acquired Infections* / epidemiology
  • Community-Based Participatory Research
  • Humans
  • Methicillin / therapeutic use
  • Methicillin-Resistant Staphylococcus aureus*
  • Soft Tissue Infections* / drug therapy
  • Soft Tissue Infections* / epidemiology
  • Stakeholder Participation
  • Staphylococcal Infections* / prevention & control
  • Staphylococcus aureus


  • Methicillin

Associated data